Cassava Sciences to Hold Conference Call on Monday, September 14, 2020 at 8:30 am ET

Rhea-AI Summary

Cassava Sciences, Inc. (Nasdaq: SAVA), a biotech company focused on Alzheimer’s disease, announced a conference call scheduled for September 14, 2020, at 8:30 a.m. Eastern Time. Details include a dial-in number for domestic and international callers and an audio webcast available on their website. The replay will be accessible for 90 days. Cassava aims to develop innovations for chronic neurodegenerative conditions, leveraging advanced technology and insights into neurobiology, with full rights to its Alzheimer’s research programs.

Positive

• Cassava Sciences focuses exclusively on Alzheimer’s disease, a significant market.
• The company holds worldwide development and commercial rights to its research programs without third-party royalty obligations.

Negative

• None.

AUSTIN, Texas, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it will hold a conference call on Monday, September 14^th at 8:30 a.m. Eastern Time. 

Event details follow:
Date:	Monday, September 14th
Time:	8:30 a.m. Eastern Time
Audio Webcast:	https://www.CassavaSciences.com/company-presentations
Dial-In:	1-800-920-4315
Conference ID:	21969265

The dial-in number for international callers is 1-212-231-2929. A replay of the webcast will remain available in the ‘Investors’ section of Cassava Sciences’ website, www.CassavaSciences.com, for 90 days following the conference. In addition, a telephonic replay of the call will be available until September 28, 2020. The replay dial-in numbers are 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers. Please use the replay conference ID number 21969265.

About Cassava Sciences, Inc.
Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer’s disease. Cassava Sciences owns worldwide development and commercial rights to its research programs in Alzheimer’s disease, and related technologies, without royalty obligations to any third-party.

For More Information Contact:
Eric Schoen, Chief Financial Officer
Cassava Sciences, Inc.
eschoen@CassavaSciences.com
(512) 501-2450

FAQ

When is the Cassava Sciences conference call scheduled?

The Cassava Sciences conference call is scheduled for September 14, 2020, at 8:30 a.m. Eastern Time.

How can I access the Cassava Sciences conference call?

You can access the conference call by dialing 1-800-920-4315 for domestic callers or 1-212-231-2929 for international callers.

What is the conference ID for the Cassava Sciences call?

The conference ID for the Cassava Sciences call is 21969265.

Will there be a replay of the Cassava call available?

Yes, a replay of the webcast will be available for 90 days in the ‘Investors’ section of Cassava Sciences’ website.

What is the focus of Cassava Sciences?

Cassava Sciences is focused on discovering and developing innovations for chronic neurodegenerative conditions, primarily Alzheimer’s disease.